Organizations Filed Purposes:
Prion Alliance, Inc aims to catalyze the development of a treatment or cure for human prion diseases by funding, organizing and promoting scientific research. Our organization supports research directed at understanding prion disease biology, discovering and testing therapeutics, and developing novel lab and computational methodologies needed for furthering this research. Our operational model is to raise funds and disburse these to the most worthy scientific projects, with a view to the projects' relevance to our ultimate goal of a treatment or cure, as well as to the projects' ability to leverage Prion Alliance, Inc seed funding in order to pursue outside funding sources for continued research. We also strive to bring together top scientific minds to share data, methodology, and findings in a spirit of openness and collaboration.
We maintained and characterized two transgenic mouse lines that our organization developed for the purposes of enabling discovery and development of human prion protein-lowering drugs.
We partnered with researchers at Utah State University to develop a new PRNP knockout hamster as a tool for PrP-lowering drug development.
We initiated development of a new PRNP knockout rat model as a tool for PrP-lowering drug development.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Eric Minikel | Treasurer | 5 | $0 |
| Greta Beekhuis | Co-director | 2 | $0 |
| Sonia Vallabh | President | 5 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202130899349301603_public.xml